At the European Society for Medical Oncology (ESMO) Congress this week, investigators presented data for a new and potentially important drug, ribociclib (Novartis). This oral medication is ...

Different types of skin rashes include those caused by allergic reactions, infections, insect bites, or health conditions. Examples include eczema, chickenpox, psoriasis, and shingles. It can be ...

An exanthem is any eruptive skin rash that may be associated with fever or other systemic symptoms. Causes include infectious pathogens, medication reactions and, occasionally, a combination of both.

Rashes and other skin changes may be a sign of COVID-19, in addition to classic symptoms like a cough, fatigue, fever, and sore throat. Some people develop a COVID rash, which can appear on body ...

Get detailed information on Ribociclib, including pronunciation, uses, dosage guidelines, indications, and instructions on how and when to take it and when to avoid it. The updated prescription ...

Mei Wei, MD, an oncologist specializing in breast cancer at Huntsman Cancer Institute at the University of Utah, discusses new treatments for HR+/HER2- breast cancer and immunotherapy challenges, ...

You’re not alone – a recent study has shown the “covid skin rash” symptom was reported in 17% of people with coronavirus. Over the past year, I’ve heard rumblings of the “covid skin ...

Ribociclib in combination with an aromatose inhibitor for previously untreated advanced or metastatic hormone receptor-positive, her2-negative breast cancer. The NICE appraisal committee wanted to ...

The team found adding ribociclib, a drug that belongs to a class of CDK4/6 inhibitors, to standard hormone therapy not only ...

Caused by the same virus behind chickenpox, shingles is a painful nerve root infection resulting in a skin rash. What does the shingles rash looks like? Who’s at risk? And who needs the shingles ...

Shower rashes can crop up for a myriad of reasons. It could be a sign of dry skin, overly hot water, or merely the result of ...

Their research suggested that neoadjuvant therapy with a combination of ribociclib and letrozole could be an alternative to multi-drug neoadjuvant chemotherapy. The trial involved high risk ...